Related Experiment Video

Updated: May 2, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

13.1K

[The function and application of the IL28B gene in HCV infection and treatment]

Ke Ma1, A-Mei Zhang2, Xue-Shan Xia2

  • 1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China. make19880710@163.com

Yi Chuan = Hereditas
|March 4, 2014
PubMed

Insights

Genetic variations in the IL28B gene, encoding Interferon lambda-3 (IFN-lambda3), influence Hepatitis C virus (HCV) clearance and treatment success. Further research into IL28B

Area of Science:

  • Hepatology and Virology
  • Immunogenetics

Background:

  • Hepatitis C virus (HCV) causes chronic liver disease, cirrhosis, and hepatocellular carcinoma.
  • Host genetics, particularly single nucleotide polymorphisms (SNPs) in the IL28B gene, affect HCV infection outcomes.
  • The IL28B gene encodes Interferon lambda-3 (IFN-lambda3), a key antiviral protein.

Purpose of the Study:

  • To investigate the association between IL28B gene polymorphisms and HCV infection.
  • To explore the role of IFN-lambda3 in viral clearance and treatment response.
  • To understand the underlying mechanisms of IL28B in HCV pathogenesis for potential therapeutic development.

Main Methods:

  • Genome-wide association studies (GWAS) were conducted on Hepatitis C patients.
  • Analysis of single nucleotide polymorphisms (SNPs) within the IL28B gene.
  • Investigation of IFN-lambda3 interaction with its receptor (IFN-lambdaR1 x IL-10R2) and downstream effects on IFN-stimulated gene factors (ISGF).

Main Results:

  • Specific IL28B gene SNPs are significantly associated with viral clearance in HCV patients.
  • These SNPs also correlate with treatment effectiveness in patients receiving PEG-IFNalpha and ribavirin (RBV).
  • IFN-lambda3 upregulates ISGF, indicating its role in the host's antiviral response.

Conclusions:

  • IL28B gene polymorphisms are crucial determinants of HCV infection and treatment outcomes.
  • IFN-lambda3's antiviral and immunoregulatory functions suggest its potential as a therapeutic target for Hepatitis C.
  • Further elucidation of the IL28B-HCV interaction mechanism is essential for developing novel antiviral drugs.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25